← All trials
NCT02962908
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2016
- Primary completion
- May 1, 2017
- Completion date
- Jul 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 170
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- SEEKLead sponsor
- University of GroningenCollaborator
- Government of NorwayCollaborator
- Robert Koch InstitutCollaborator
- Isala Clinics, Zwolle, The NetherlandsOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.